After getting smallpox vaccine ACAM2000 from Sanofi and an anthrax treatment called raxibacumab from GlaxoSmithKline, Emergent BioSolutions is buying again,…
Super UserAugust 22, 2022
Emergent BioSolutions is mobilizing its M&A war chest again. Hard on the heels of its $270 million deal for vaccine…
Super UserAugust 22, 2022
We just released 8 new high priority funding opportunities where your company can make a difference in meeting the needs…
Super UserAugust 19, 2022
SEATTLE, Aug. 16, 2022 (GLOBE NEWSWIRE) -- AGC Biologics, a leading global Biopharmaceutical Contract Development and Manufacturing Organization (CDMO), announced today…
Super UserAugust 19, 2022
The Washington, D.C./Baltimore region continued to see a tightening in its life sciences real estate market. In particular, the region…
Super UserAugust 19, 2022
The fiscal year 2022 program is now closed. The fiscal year 2023 program will begin accepting applications as follows: Commerce…
Super UserAugust 19, 2022
Aug 15, 2022 If authorized, Novavax' vaccine would be the first protein-based COVID-19 booster for adults If authorized, the Novavax…
Super UserAugust 19, 2022
Two new medical startups, focusing on addressing vision loss and catheter-associated urinary tract infections (UTIs), are on the horizon thanks…
Super UserAugust 19, 2022
Trouble Viewing This Email: Click Here August 16, 2022 FOUNDING MEMBER OF BHI Seeks Senior Life Sciences Business…
Super UserAugust 16, 2022